相似文献
1
Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.
Nucleic Acids Res. 2001 May 15;29(10):2041-51. doi: 10.1093/nar/29.10.2041.
2
Selective degradation of targeted mRNAs using partially modified oligonucleotides.
Methods Enzymol. 2000;313:420-36. doi: 10.1016/s0076-6879(00)13026-5.
3
Pathways of degradation and mechanism of action of antisense oligonucleotides in Xenopus laevis embryos.
Antisense Res Dev. 1991 Spring;1(1):11-20. doi: 10.1089/ard.1991.1.11.
4
Targeted degradation of mRNA in Xenopus oocytes and embryos directed by modified oligonucleotides: studies of An2 and cyclin in embryogenesis.
Nucleic Acids Res. 1990 Aug 25;18(16):4751-7. doi: 10.1093/nar/18.16.4751.
5
Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
Biochemistry. 1997 Jan 14;36(2):390-8. doi: 10.1021/bi962230p.
6
Prediction of antisense oligonucleotide binding affinity to a structured RNA target.
Biotechnol Bioeng. 1999 Oct 5;65(1):1-9.
7
Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Mol Ther. 2001 Nov;4(5):454-60. doi: 10.1006/mthe.2001.0481.
8
Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA.
Nucleic Acids Res. 2003 Nov 1;31(21):6365-72. doi: 10.1093/nar/gkg820.
9
Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts.
Nucleic Acids Res. 1998 Nov 15;26(22):5079-85. doi: 10.1093/nar/26.22.5079.
10
CPEB controls the cytoplasmic polyadenylation of cyclin, Cdk2 and c-mos mRNAs and is necessary for oocyte maturation in Xenopus.
EMBO J. 1996 May 15;15(10):2582-92.
引用本文的文献
1
Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.
BioDrugs. 2024 Jul;38(4):511-526. doi: 10.1007/s40259-024-00665-2. Epub 2024 Jun 25.
2
RNA interference as a novel treatment strategy for chronic hepatitis B infection.
Clin Mol Hepatol. 2022 Jul;28(3):408-424. doi: 10.3350/cmh.2022.0012. Epub 2022 Feb 17.
3
Microarrays for identifying binding sites and probing structure of RNAs.
Nucleic Acids Res. 2015 Jan;43(1):1-12. doi: 10.1093/nar/gku1303. Epub 2014 Dec 12.
4
Mapping targetable sites on human telomerase RNA pseudoknot/template domain using 2'-OMe RNA-interacting polynucleotide (RIPtide) microarrays.
J Biol Chem. 2012 May 25;287(22):18843-53. doi: 10.1074/jbc.M111.316596. Epub 2012 Mar 26.
5
siRNAs target sites selection of ezrin and the influence of RNA interference on ezrin expression and biological characters of osteosarcoma cells.
Mol Cell Biochem. 2012 May;364(1-2):363-71. doi: 10.1007/s11010-012-1238-6.
6
Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.
J Ophthalmol. 2011;2011:531380. doi: 10.1155/2011/531380. Epub 2011 Jun 30.
7
Ezrin mRNA target site selection for DNAzymes using secondary structure and hybridization thermodynamics.
Tumour Biol. 2011 Aug;32(4):809-17. doi: 10.1007/s13277-011-0183-4. Epub 2011 May 11.
8
Systematic analysis of the role of target site accessibility in the activity of DNA enzymes.
J RNAi Gene Silencing. 2006 Jul 28;2(2):205-14.
9
Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites.
Retrovirology. 2007 Apr 26;4:29. doi: 10.1186/1742-4690-4-29.
10
Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation.
Nucleic Acids Res. 2006;34(19):5660-9. doi: 10.1093/nar/gkl715. Epub 2006 Oct 11.
本文引用的文献
1
Using oligonucleotide scanning arrays to find effective antisense reagents.
Methods Mol Biol. 2001;170:181-99. doi: 10.1385/1-59259-234-1:181.
2
Hybridization of antisense reagents to RNA.
Curr Opin Mol Ther. 2000 Jun;2(3):264-71.
3
Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity.
Nucleic Acids Res. 2000 Aug 1;28(15):2862-5. doi: 10.1093/nar/28.15.2862.
4
Theoretical design of antisense genes with statistically increased efficacy.
Nucleic Acids Res. 2000 Jul 1;28(13):2597-604. doi: 10.1093/nar/28.13.2597.
5
Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.
Biochim Biophys Acta. 1999 Dec 10;1489(1):53-68. doi: 10.1016/s0167-4781(99)00141-4.
6
Antisense arrays.
Mol Cell Biol Res Commun. 2000 Feb;3(2):67-72. doi: 10.1006/mcbr.2000.0178.
7
Effects of RNA secondary structure on cellular antisense activity.
Nucleic Acids Res. 2000 Mar 15;28(6):1340-7. doi: 10.1093/nar/28.6.1340.
8
A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability.
Nucleic Acids Res. 1999 Nov 15;27(22):4328-34. doi: 10.1093/nar/27.22.4328.
9
Determining the influence of structure on hybridization using oligonucleotide arrays.
Nat Biotechnol. 1999 Aug;17(8):788-92. doi: 10.1038/11732.
10
Designing ribozymes for the inhibition of gene expression.
Trends Biotechnol. 1998 Oct;16(10):434-8. doi: 10.1016/s0167-7799(98)01236-0.
Zotero 插件